arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Dogwood Therapeutics, Inc.

DWTX

$1.07 ▲ +0.04 (+3.38%) at close

27 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Dogwood Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $36.5M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -16.3% ↘

FCF / Share $-0.11 ↗

Trailing P/E —

Price / Book 0.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-4.99M

↑ +54.4% —

FCF / Share Free cash flow per share

$-0.11

↑ +22.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	82.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	98.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-300.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-3880.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-11971.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-433.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-3316.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	12.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	78.6% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	81.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	83.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	54.4% Excellent ↑ Excellent Improving Year-over-year change in net income	54.4% Excellent ↑ Excellent Improving Year-over-year change in net income	51.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-746.0% Weak ↓ Weak Declining Year-over-year change in net income	-746.0% Weak ↓ Weak Declining Year-over-year change in net income	-746.0% Weak ↓ Weak Declining Year-over-year change in net income	-600.5% Weak ↓ Weak Declining Year-over-year change in net income	14.9% Fair ↓ Fair Declining Year-over-year change in net income	14.9% Fair ↓ Fair Declining Year-over-year change in net income	14.9% Fair ↓ Fair Declining Year-over-year change in net income	46.0% Excellent ↓ Excellent Declining Year-over-year change in net income	61.7% Excellent → Excellent Stable Year-over-year change in net income	61.7% Excellent ↑ Excellent Improving Year-over-year change in net income	61.7% Excellent ↑ Excellent Improving Year-over-year change in net income	54.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-29.6% Weak ↓ Weak Declining Year-over-year change in net income	-29.6% Weak ↑ Weak Improving Year-over-year change in net income	-29.6% Weak ↑ Weak Improving Year-over-year change in net income	30.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-555.0% Weak → Weak Stable Year-over-year change in net income	-555.0% Weak Weak Year-over-year change in net income	-555.0% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	95.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-6573.2% Weak Weak Year-over-year change in free cash flow	—	—	—	47.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	70.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	437.8% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.72x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.67x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.20x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.66x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-16.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-172.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	58.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-191.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-39.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-16.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-17.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-100.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-40.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	—	-23.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-20.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-7.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-6.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-5.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-150.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1103%)	-158.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1159%)	-154.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1128%)	76.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+409%)	-136.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1007%)	-41.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-375%)	-48.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-424%)	-29.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-293%)	-31.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-312%)	-32.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-316%)	-25.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-269%)	-27.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-286%)	-42.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-386%)	-55.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-470%)	-37.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-347%)	-31.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-307%)	-16.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-13.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-11.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-175%)	-21.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-672.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.63x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-9.61M	$-13.23M	$-6.52M	$-10.13M	$-13.40M	$-17.54M	$-14.85M	$-2.04M	$-3.02M	$-2.38M	$-3.32M	$-4.79M	—	$-5.33M	$-7.03M	$-9.79M	$-7.70M	$-11.35M	$-14.01M	$-19.19M	$-21.84M	$-24.59M	$-29.80M	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.34	$-0.15	$10.89	$-8.20	$-1.99	$-8.45	$-7.57	$-2.05	$-0.05	$-0.07	$-1.42	$-0.06	$-0.08	$-0.08	$0.07	$-0.28	$-0.44	$-0.48	$-0.55	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.11	$-0.14	—	$-1.71	—	$-3.25	—	—	—	$-0.05	—	—	$-0.04	$-0.09	—	—	$0.00	$-0.32	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.03	$2.41	$2.52	$3.17	$3.60	$3.71	$-0.36	$0.03	$0.11	$0.14	$4.94	$0.25	$0.25	$0.33	$0.40	$0.50	$0.86	$1.28	$1.74	$2.27	$2.74	$3.25	$3.61	—	—	—	—
Tangible Book Value per Share (USD)	$-0.03	$0.02	$-0.22	$-31.78	$-39.18	$-36.89	$-3.16	$0.03	$0.11	$0.14	$4.94	$0.25	$0.25	$0.33	$0.40	$0.50	$0.86	$1.28	$1.74	$2.27	$2.74	$3.25	$3.61	—	—	—	—
Basic Weighted Avg Shares (shares)	34.13M	33.54M	—	1.92M	1.91M	1.44M	—	1.11M	22.90M	19.26M	—	19.09M	18.41M	18.33M	—	9.20M	8.33M	8.33M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$8.19M	$12.44M	$5.37M	$9.06M	$12.82M	$16.58M	$13.37M	$949.43K	$3.14M	$2.65M	$3.81M	$4.76M	—	$5.97M	$7.33M	$9.22M	$7.14M	$10.67M	$14.50M	$18.88M	$22.86M	$27.11M	$29.94M	—	—	—	—
Total Equity (USD)	$68.37M	$80.62M	$74.90M	$7.26M	$6.88M	$7.09M	$-10.12M	$949.43K	$3.14M	$2.65M	$3.81M	$4.76M	$4.69M	$5.97M	$7.33M	$9.22M	$7.14M	$10.67M	$14.50M	$18.88M	$22.86M	$27.11M	$29.94M	—	—	—	$-5.02M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	—	—	$0.00	$-32.22K	—	$17.02K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-4.99M	$-4.99M	$-3.78M	$-10.92M	$-10.92M	$-10.92M	$-7.73M	$-1.29M	$-1.29M	$-1.29M	$-1.10M	$-1.52M	$-1.52M	$-1.52M	$-2.04M	$-3.96M	$-3.96M	$-3.96M	$-4.51M	$-3.06M	$-3.06M	$-3.06M	$-6.50M	$-466.55K	$-466.55K	$-466.55K	—
Operating Cash Flow (USD)	$-3.61M	$-4.59M	$-3.64M	$-3.27M	—	$-4.68M	$-6.13M	—	—	$-937.41K	$-1.47M	—	$-742.41K	$-1.70M	$-2.67M	—	$0.00	$-2.66M	$-5.18M	—	—	$-5.11M	$-2.29M	$-558.89K	$-772.57K	$-277.38K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 27 quarters

Dogwood Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DWTX with peers